Merck CEO Stresses Need For ‘Fair Return’ On COVID-19 Interventions

Also Shares Views On US Pricing Moves

Merck & Co’s chief executive shares views on the need for “reasonable” returns on COVID-19 therapeutics and vaccines, and on the future US pricing environment, at the USAIC summit.

RAHWAY, NJ - JULY 17: A sign at the entrance to a Merck plant in Rahway, New Jersey on July 17, 2017. Merck is an American pharmaceutical company.
CEO Frazier Talks COVID-19, US Drug Pricing • Source: Shutterstock

Merck & Co., Inc. chairman and chief executive officer Kenneth Frazier took on a host of burning questions, including around the pricing of potential COVID-19 therapeutics and vaccines, and on the recent controversial US executive orders, at the star-studded virtual edition of the Annual BioPharma and Healthcare Summit of the USAIC (USA-India Chamber of Commerce).

The CEO minced no words, saying that while Merck will strive to make its pandemic-related medicines broadly accessible and affordable,...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip